Quantcast
Last updated on April 18, 2014 at 9:07 EDT

Latest Antiretroviral drug Stories

shutterstock_70591327
2012-07-24 23:17:46

Lee Rannals for redOrbit.com - Your Universe Online An AIDS Conference in Washington D.C. on Tuesday gave hope in the search for finding a cure for the disease that caused nearly 30 million deaths since the 1980s. With around 34 million people around the world living with HIV, experts say a cure is more crucial than ever before, because the rate of infections is outpacing the world's ability to medicate people. "For every person who starts antiretroviral therapy, two new individuals...

2012-07-24 11:05:59

Lancet paper finds novel drug regimen could be more effective than existing treatments; TB Alliance's trial to test drugs in combination saves years in research time A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments, according to a study published today in the...

2012-07-24 02:28:18

CARLSBAD, Calif., July 24, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE ) today announced a collaboration with the Southern African Treatment and Resistance Network (SATuRN - http://www.bioafrica.net/saturn) on sequencing-based diagnostics for HIV-infected individuals in Africa. Antiretroviral (ARV) drugs are becoming increasingly available in the developing world, due to facilitation by both governmental and non-governmental organizations, as well as reductions...

2012-07-23 12:27:25

HIV-infected young adults, blacks, injection drug users and the uninsured less likely to have disease under control while taking antiretroviral drugs Tens of thousands of Americans taking potent antiretroviral therapies, or ART, to keep their HIV disease in check may not have as much control over the viral infection as previous estimates have suggested, according to results of a study by AIDS experts at Johns Hopkins and the University of Pennsylvania. In what is believed to be the...

2012-07-19 06:37:48

(Ivanhoe Newswire) — A new medical essay argues switching patients on one type of antiretroviral therapy (ART) to another, to see whether the new drug is as good as the preventing replication of the HIV virus, may be unethical and may not benefit patients. The studies, termed non-inferiority trials, are only ethical if participants can meaningfully benefit from the treatment change and are more likely to benefit than suffer harm, according to Andrew Carr from the HIV unit in St...

2012-07-19 00:36:32

A new collection of compounds, called "bryologs" — derived from a tiny marine organism — activate hidden reservoirs of the virus that currently make the disease nearly impossible to eradicate. Thanks to antiretrovirals, an AIDS diagnosis hasn't been a death sentence for nearly two decades. But highly active antiretroviral therapy, or HAART, is also not a cure. Patients must adhere to a demandingly regular drug regimen that carries plenty of side effects. And while the...

2012-07-17 22:22:45

LONDON, July 18, 2012 /PRNewswire/ -- ViiV Healthcare today announced a broad range of groundbreaking initiatives as part of its ongoing commitment to address the gaps in care and treatment of paediatric HIV. These efforts are part of the company's Paediatric Innovation Seed Fund. They include a public-private partnership with CHAI and Mylan Laboratories Limited, a subsidiary of US-based Mylan Inc., to submit a registration file for a new dispersible formulation of a fixed dose combination...

HIV Prevention Pill Truvada Approved by FDA
2012-07-17 09:18:10

Connie K. Ho for redOrbit.com — Your Universe Online The U.S. Food and Drug Administration (FDA) recently approved Truvada, which decreases the risk of HIV invention in uninfected individuals who have a high risk of contracting HIV Infection or who are engaged in sexual activities with a partner who is HIV-infected. Truvada is the first drug approved by the FDA that focuses on reducing the risk of HIV infection acquired through sexual activities. Taken daily, the drug is be used...

2012-07-11 14:20:47

AVAC Lays out Priorities to Ensure Access NEW YORK, July 11, 2012 /PRNewswire-USNewswire/ -- Publication of data from three trials of pre-exposure prophylaxis (PrEP) for HIV - including the pivotal Partners PrEP trial - today in the New England Journal of Medicine provides strong evidence that HIV-negative men and women who consistently take a daily antiretroviral (ARV) pill (either TDF/FTC, brand name Truvada, or TDF, brand name Viread) can significantly reduce their risk of HIV...

2012-07-11 14:20:33

RESEARCH TRIANGLE PARK, N.C., July 11, 2012 /PRNewswire-USNewswire/ -- Results of the FHI 360 FEM-PrEP HIV-prevention trial reinforce the key role of adherence in HIV-prevention studies and the need to determine better approaches to support adherence in future pre-exposure prophylaxis (PrEP) programs. Despite targeted counseling and support, adherence to the drug regimen was low, suggesting that women in the clinical trial population may have had difficulty adhering to a daily pill regimen....


Latest Antiretroviral drug Reference Libraries

0_a4499f7c8759b5cbe79bad5eca319070
2011-01-26 14:08:59

Human immunodeficiency virus (HIV), a lentivirus, causes acquired immunodeficiency syndrome (AIDS) which is a condition in humans were the immune system begins to fail, leading to life-threatening opportunistic infections. Infection is transferred through bodily fluids where HIV is present as both free virus particles and within infected immune cells. The four most common routes of infection are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her...

More Articles (1 articles) »